This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Innovations of Nicholas Draeger in Protein Production
Introduction
Nicholas Draeger is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the production and purification of hydrophobic polypeptides and proteins. His work has implications for drug development and understanding amyloid toxicity.
Latest Patents
Draeger holds a patent for a process that focuses on producing hydrophobic polypeptides and proteins. This patent, titled "Process for producing hydrophobic polypeptides and proteins, and fusion," outlines methods for the production and purification of hydrophobic fusion proteins. It also includes the development of homogeneous monomeric β-amyloid peptide, which is crucial for screening drugs that inhibit amyloid toxicity.
Career Highlights
Nicholas Draeger is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His work at this organization has allowed him to collaborate with other experts in the field, enhancing the impact of his research.
Collaborations
Draeger has worked alongside notable colleagues such as Heinz Dobeli and Gerda Huber Trottman. Their combined expertise has contributed to advancements in the understanding of protein behavior and its applications in medicine.
Conclusion
Nicholas Draeger's innovative work in the production of hydrophobic proteins has the potential to influence drug development significantly. His contributions to biochemistry are noteworthy and continue to pave the way for future research in the field.